Skip to content
HowShorted

Corbus Pharmaceuticals Holdings, Inc. short interest in 2018

In 2018, Corbus Pharmaceuticals Holdings, Inc.'s disclosed short interest ran from 13.13% of shares outstanding on 12 Jan 2018 to 22.44% on 31 Dec 2018, a change of +9.31 percentage points. The year's high was 25.40% on 31 Oct 2018 and its low 13.01% on 31 Jan 2018, averaging 18.51% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 36.83 days on 15 Aug 2018. Full history: Corbus Pharmaceuticals Holdings, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Corbus Pharmaceuticals Holdings, Inc. in 2018

2018 in figures

Start of year
13.13% (12 Jan 2018)
End of year
22.44% (31 Dec 2018)
Change
+9.31 pp
High
25.40% (31 Oct 2018)
Low
13.01% (31 Jan 2018)
Average
18.51%
Highest days to cover
36.83 (15 Aug 2018)
SEC filings marked
8

Every report in 2018

Corbus Pharmaceuticals Holdings, Inc. short interest in 2018
SettlementShort interestDays to coverFilings since previous
12 Jan 201813.13%6.83
31 Jan 201813.01%5.11
15 Feb 201815.96%7.59
28 Feb 201814.43%12.95
15 Mar 201815.20%12.2410-K filed, results (8-K)
29 Mar 201815.69%11.76
13 Apr 201816.36%17.47
30 Apr 201816.29%26.75
15 May 201816.04%11.7410-Q filed, results (8-K)
31 May 201816.41%21.29
15 Jun 201816.34%18.20
29 Jun 201816.45%18.64
13 Jul 201815.73%28.09
31 Jul 201816.42%22.61
15 Aug 201819.41%36.8310-Q filed, results (8-K)
31 Aug 201819.81%29.18
14 Sep 201819.88%24.02
28 Sep 201823.26%3.29
15 Oct 201824.52%8.10
31 Oct 201825.40%11.29
15 Nov 201824.67%15.5910-Q filed, results (8-K)
30 Nov 201824.06%34.10
14 Dec 201823.32%26.42
31 Dec 201822.44%19.54

See also: Corbus Pharmaceuticals Holdings, Inc.'s full history · most shorted US stocks of 2018 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.